Hillsdale Investment Management Inc. Royalty Pharma PLC Transaction History
Hillsdale Investment Management Inc.
- $1.79 Billion
- Q4 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 24,250 shares of RPRX stock, worth $787,155. This represents 0.03% of its overall portfolio holdings.
Number of Shares
24,250
Previous 23,650
2.54%
Holding current value
$787,155
Previous $669,000
7.62%
% of portfolio
0.03%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.28 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$747 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$551 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$459 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...